Rui Kang Pharmaceutical Group Investments Ltd (8037) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Rui Kang Pharmaceutical Group Investments Ltd (Rui Kang Pharmaceutical), formerly Longlife Group Holdings Ltd is an investment holding company that offers pharmaceutical products and services. The company manufactures, research, develops, and distributes commodities including dietary products, cosmetics, body products and health supplement wine. It also trades dental materials and equipment. Rui Kang Pharmaceutical also offers medical laboratory testing and health check services. The company offers its products and services in China and Hong Kong. It operates in China, Hong Kong and the UK. Rui Kang Pharmaceutical is headquartered in Hong Kong.
Rui Kang Pharmaceutical Group Investments Ltd (8037) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Rui Kang Pharmaceutical Group Investments Ltd (Rui Kang Pharmaceutical), formerly Longlife Group Holdings Ltd is an investment holding company that offers pharmaceutical products and services. The company manufactures, research, develops, and distributes commodities including dietary products, cosmetics, body products and health supplement wine. It also trades dental materials and equipment. Rui Kang Pharmaceutical also offers medical laboratory testing and health check services. The company offers its products and services in China and Hong Kong. It operates in China, Hong Kong and the UK. Rui Kang Pharmaceutical is headquartered in Hong Kong.
Rui Kang Pharmaceutical Group Investments Ltd (8037) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
3
List of Tables 4
List of Figures 4
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Rui Kang Pharma Raises USD2.5 Million in Private Placement of Shares 10
Rui Kang Pharma to Raise USD6.09 Million in Private Placement of Shares 11
Acquisition 12
Genius Lead to Acquire 11% Stake in Rui Kang Pharma from New Ray Medicine for USD5.64 million 12
Longlife Group To Acquire Guiyang Shu Mei Da Pharma 13
Rui Kang Pharmaceutical Group Investments Ltd - Key Competitors 14
Rui Kang Pharmaceutical Group Investments Ltd - Key Employees 15
Rui Kang Pharmaceutical Group Investments Ltd - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 10, 2017: Rui Kang Pharmaceutical Group Investments: Interim Results Announcement For The Six Months Ended 30 June 2017 17
Corporate Communications 20
Sep 15, 2017: Rui Kang Pharmaceutical Group Investments: Appointment of Non-executive Director 20
Apr 18, 2017: Rui Kang Pharmaceutical Group Investments: Appointment Of Non-Executive Director; Resignation Of Executive Director And Change Of Chief Executive Officer 21
Other Significant Developments 23
Sep 15, 2017: Rui Kang Pharmaceutical Group: Proposed Change Of Company Name 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Tables
List of TablesRui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rui Kang Pharmaceutical Group Investments Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Rui Kang Pharmaceutical Group Investments Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rui Kang Pharma Raises USD2.5 Million in Private Placement of Shares 10
Rui Kang Pharma to Raise USD6.09 Million in Private Placement of Shares 11
Genius Lead to Acquire 11% Stake in Rui Kang Pharma from New Ray Medicine for USD5.64 million 12
Longlife Group To Acquire Guiyang Shu Mei Da Pharma 13
Rui Kang Pharmaceutical Group Investments Ltd, Key Competitors 14
Rui Kang Pharmaceutical Group Investments Ltd, Key Employees 15
Rui Kang Pharmaceutical Group Investments Ltd, Subsidiaries 16
RELATED REPORTS
Apoptosis Associated Speck Like Protein Containing A CARD (Caspase Recruitment Domain Containing Protein 5 or PYD And CARD Domain Containing Protein or Target Of Methylation Induced Silencing 1 or ASC or PYCARD) - Drugs in Development, 2021
Apoptosis Associated Speck Like Protein Containing A CARD (Caspase Recruitment Domain Containing Protein 5 or PYD And CARD Domain Containing Protein or Target Of Methylation Induced Silencing 1 or ASC
View ReportBruise (Contusion) Global Clinical Trials Review, H1, 2017
Bruise (Contusion) Global Clinical Trials Review, H1, 2017GlobalDatas clinical trial report, Bruise (Contusion) Global Clinical Trials Review, H1, 2017 provides an overview of Bruise (Contusion) clinical trials scenario. This report
View ReportRui Kang Pharmaceutical Group Investments Ltd (8037) - Financial and Strategic SWOT Analysis Review
Rui Kang Pharmaceutical Group Investments Ltd (Rui Kang Pharmaceutical), formerly Longlife Group Holdings Ltd is an investment holding company that offers pharmaceutical products and services. The company manufactures, research, develops,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
